Published 2024 | Version v1
Publication

Montelukast improves disease outcomes in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity

Additional details

Created:
July 5, 2024
Modified:
July 5, 2024